Quick Takeaways
- Jake Simson has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $159,750.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Jake Simson
- Location
- La Jolla, CA
- Summary
- The estimated net worth of Jake Simson is at least $159,750 dollars as of 20 Jun 2025. Jake Simson is the Director of Janux Therapeutics, Inc. and owns shares of Janux Therapeutics, Inc. (JANX) stock worth about $159.8K.
- Signature
- /s/ Jeffrey Finer, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jake Simson and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Janux Therapeutics, Inc. ($159,750).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Jake Simson
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | Director | $159,750 | 11 Jun 2025 | ||
| BCAX | Bicara Therapeutics Inc. | Director | 09 Jun 2025 | |||
| DICE | DICE Therapeutics, Inc. | Director | 09 Aug 2023 | |||
| SEPN | Septerna, Inc. | Director | 17 Jun 2025 | |||
| TYRA | Tyra Biosciences, Inc. | Director | 29 May 2025 |
Insider Transactions Reported by Jake Simson:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.